Challita-Eid et al. (2007) first generated two mAbs that bind to cell surface STEAP1 epitopes, and both of them inhibited STEAP1-induced intercellular communication in a dose-dependent manner to suppress tumor growth in vivo. The gene discussed is STEAP1; the disease is neoplasm.